<p>The Office of Cancer Genomics (OCG) at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing  technologies in cancer. The CGCI program included comprehensive characterization of the genetic aberrations found in different pediatric and/or adult</p>

National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin study with RNA-Seq, WGS + 1 more data on dbGaP (118 participants)